NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its fourth quarter and full year 2025 financial results on March 11, 2026 after the markets close. Management will host a conference call on March 12, 2026 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at Ma ...

The Brand’s First-Ever Swirled Chew Combines Strawberry and Chocolate Flavors Plus CBG and Horny Goat Weed for Libido-enhancing FunNORWOOD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Betty’s Eddies™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine’s Day: Berry In Love Betty. Betty’s Eddies is one of the top-selling and award-winning brands developed and distri ...

NORWOOD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced the launch of a hemp-derived THC version of its Vibations™ hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental cultivation ...

Core Viewpoint - The reclassification of cannabis as a Schedule III drug by the Trump Administration is a significant reform that acknowledges its medical uses and low abuse potential, which will have long-term benefits for the cannabis industry [2]. Group 1: Impact of Reclassification - The reclassification is expected to accelerate accredited medical research into cannabis-derived medications, leading to increased consumer acceptance of cannabis as an alternative to opioids for chronic pain, sleep, anxiety, and other ailments [3]. - State-legal cannabis businesses will benefit from the removal of the IRS Section 280E tax penalty, allowing compliant operators like MariMed to be taxed similarly to other consumer packaged goods sectors, which will enhance profitability and free cash flow [4]. Group 2: Company Overview - MariMed Inc. is recognized as a leading multi-state cannabis operator, specializing in the development and management of advanced cultivation, production, and retail facilities [4]. - The company boasts an award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby's Baked™, Vibations™, InHouse™, and Nature's Heritage™, which are well-regarded by consumers nationwide [4].

Core Insights - MariMed Inc. has launched an initiative featuring an original song inspired by U.S. Army veteran Ryan Taylor, highlighting the company's commitment to veteran-focused initiatives and the positive impact of medical cannabis on veterans' lives [1][4]. Group 1: Initiative Overview - The initiative is inspired by Ryan Taylor's transformative experience with medical cannabis, which provided him relief from the physical and emotional wounds of combat [1][4]. - The song, titled "Thrive: Anna," will be played in-store across all 13 Thrive Dispensary locations in multiple states, including Massachusetts, Ohio, Delaware, Maryland, and Illinois [2]. Group 2: Community Engagement - Before the song airs, a recorded introduction from a veteran team member will provide context about the song and recognize FreedomSingsUSA, a nonprofit that helps veterans share their stories through music [3]. - MariMed will make a donation to FreedomSingsUSA in honor of Ryan Taylor, further supporting veteran initiatives [3]. Group 3: Company Background - MariMed Inc. is recognized as a leading multi-state cannabis operator, known for its innovative cultivation, production, and retail facilities [6]. - The company has a portfolio of award-winning cannabis brands, which are well-regarded by consumers across the country [6].

Bundle Up Betty’s Uses Real Cranberry, Orange, and Warming Spices in Each Fruit Chew to Deliver Cozy Winter Wind-DownsNORWOOD, Mass., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Betty’s Eddies™, the all-natural, cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of cranberry orange chews for the winter: Bundle Up Betty’s. Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state ca ...

NORWOOD, Mass., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Betty’s Eddies™, the all-natural, cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of cranberry orange chews for the winter: Bundle Up Betty’s. Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD). Now available at select cannabis retailers throug ...

MariMed Inc. (MRMD) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced break-even earnings, delivering a surprise of +100%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.MariMed Inc., which belongs to the ...

Core Insights - MariMed Inc. reported financial results for Q3 2025, highlighting sequential growth in revenue, adjusted EBITDA, and operating cash flow, driven by wholesale sales and expansion into new markets [2][3] Financial Performance - Revenue for Q3 2025 was $40.8 million, slightly up from $40.6 million in Q3 2024 [3] - GAAP gross margin decreased to 40% from 41% year-over-year, while non-GAAP gross margin also fell to 41% from 43% [3] - The company reported a GAAP net loss of $2.9 million compared to a loss of $1.0 million in Q3 2024, and a non-GAAP net loss of $1.5 million, down from a net income of $0.5 million in the same period last year [3] - Non-GAAP adjusted EBITDA increased to $5.1 million from $4.7 million year-over-year, with an adjusted EBITDA margin of 13% [3] Operational Highlights - The company expanded its distribution of Betty's Eddies™ to Maine and entered into a Managed Services Agreement in Pennsylvania [5][6] - New agreements were established to distribute products in high-growth states like Pennsylvania and New York, with anticipated distribution starting in 2026 [6][10] - The launch of adult-use sales in Delaware contributed to revenue growth, despite facing competition in Illinois [2][5] Cash Flow and Assets - Cash and cash equivalents at the end of Q3 2025 were $6.6 million, down from $7.3 million at the end of 2024 [19] - Total current assets increased to $60.1 million from $53.5 million year-over-year, driven by higher inventory levels [19] - Total liabilities rose to $136.6 million from $129.4 million, with current liabilities also increasing [19] Strategic Initiatives - The company is focused on owning top-selling national cannabis brands and expanding its brand portfolio into new markets [2] - MariMed's management emphasized disciplined cost management and operational efficiencies to improve profitability [2]

Core Insights - MariMed Inc. has announced manufacturing and distribution agreements to launch its beverage and edibles brands, including Vibations™ and Betty's Eddies™, into the hemp-derived THC market [1][2] - The initiative is part of MariMed's "Expand the Brand" strategy aimed at extending its product portfolio into new categories and markets across the U.S. [2] - The hemp beverage market generated $3.3 billion in 2024 and is projected to nearly double by 2029, presenting a significant growth opportunity for MariMed [4] Company Strategy - The first product to be launched will be a hemp-derived THC version of the Vibations hydrating drink mix, with distribution expected in Rhode Island by early Q1 2026 [2] - MariMed is developing distribution plans for Vibations and Betty's Eddies, which are consistently top-selling cannabis edibles in core markets [3] - A new business unit, MMA Hemp Inc., has been established to manage the company's hemp-derived THC activities [4] Market Position - Vibations is ranked among the top 10 selling cannabis beverage brands in Illinois, Massachusetts, Maryland, and Delaware [2] - The company aims to establish itself as a leader in the national cannabis brand space within the next five years, leveraging partnerships with established leaders in manufacturing and distribution [4]